Corcept Therapeutics (CORT) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $115.37 +1.22%
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +393.8%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.11, $0.03 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $42.8 million versus the consensus estimate of $42.03 million.
GUIDANCE:
Corcept Therapeutics sees FY2017 revenue of $157-162 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
